Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)

ClinicalTrials.gov ID: NCT02466425

Public ClinicalTrials.gov record NCT02466425. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 10:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Multi-center, Placebo Controlled, Dose-Optimization, Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)

Study identification

NCT ID
NCT02466425
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Shire
Industry
Enrollment
264 participants

Conditions and interventions

Interventions

  • SHP465 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
6 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 17, 2015
Primary completion
Feb 15, 2016
Completion
Feb 15, 2016
Last update posted
Jun 2, 2021

2015 – 2016

United States locations

U.S. sites
36
U.S. states
19
U.S. cities
34
Facility City State ZIP Site status
Harmonex Neuroscience Research Dothan Alabama 36303
Nrc Research Institute Orange California 92868
Pcsd Feighner Research San Diego California 92108
Encompass Clinical Research Spring Valley California 91978
Elite Clinical Trials, Inc Wildomar California 92595
McB Clinical Research Centers Colorado Springs Colorado 80910
Florida Clinical Research Center, Llc Bradenton Florida 34201
Sarkis Clinical Trials Gainesville Florida 32607
Clinical Neuroscience Solutions, Inc. Jacksonville Florida 32256
Medical Research Group of Central Florida Orange City Florida 32763
Clinical Neuroscience Solutions, Inc. Orlando Florida 32801
Miami Research Associates, Llc South Miami Florida 33143
Janus Center For Psychiatric Research West Palm Beach Florida 33407
Northwest Behavioral Research Center Marietta Georgia 30060
Capstone Clinical Research Libertyville Illinois 60048
Baber Research Group Inc Naperville Illinois 60563
Psychiatric Associates Overland Park Kansas 66211
Louisiana Research Associates, Inc New Orleans Louisiana 70114
Rochester Center For Behavioral Medicine Rochester Hills Michigan 48307
Psychiatric Care and Research Center O'Fallon Missouri 63368
Midwest Research Group Saint Charles Missouri 63304
Center For Psychiatry and Behavioral Medicine Las Vegas Nevada 89128
Midwest Clinical Research Center Dayton Ohio 45417
Tulsa Clinical Research, Llc Tulsa Oklahoma 74104
Oregon Center For Clinical Investigations, Inc Salem Oregon 97301
Omega Medical Research Warwick Rhode Island 02886
Rainbow Research Barnwell South Carolina 29812
Coastal Carolina Research Center Mt. Pleasant South Carolina 29464
Clinical Neuroscience Solution, Inc Memphis Tennessee 38119
Futuresearch Trials of Dallas, Lp Dallas Texas 75231
Bayou City Research Houston Texas 77007
Red Oak Psychiatry Associates, Pa Houston Texas 77090
Houston Clinical Trials, Llc Houston Texas 77098
Westex Clinical Investigations Lubbock Texas 79423
Research Across America Plano Texas 75093
Eastside Therapeutic Resource Kirkland Washington 98033

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02466425, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 2, 2021 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02466425 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →